Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how
R Liga, A Colli, DP Taggart, WE Boden… - Journal of the …, 2023 - Am Heart Assoc
Background Myocardial revascularization has been advocated to improve myocardial
function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for …
function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for …
A eficácia do Sacubitril/Valsartana no tratamento da insuficiência cardíaca
ACD de Souza, LMO La Croix… - Revista Eletrônica …, 2022 - acervomais.com.br
Objetivo: Analisar o tratamento padrão da Insuficiência Cardíaca comparada ao
Sacubitril/Valsartana, a fim de compreender os pacientes que poderão se beneficiar desta …
Sacubitril/Valsartana, a fim de compreender os pacientes que poderão se beneficiar desta …
[PDF][PDF] A Review on the Wonder Drug: Sacubitril-Valsartan
P Aakunuri, VP Pittu, K Snehalatha, SP Vamshi - academia.edu
There are an estimated 17.9 million people worldwide who have heart failure, despite the
widespread use of guideline-directed medical therapies such as angiotensin-converting …
widespread use of guideline-directed medical therapies such as angiotensin-converting …